CStone Pharmaceuticals Valuation
| CSPHF Stock | USD 0.70 0.00 0.00% |
CStone Pharmaceuticals is overvalued. CStone Pharmaceuticals shows a prevailing Real Value of $0.63 per share. The current price of the firm is $0.7. Our model approximates the value of CStone Pharmaceuticals from analyzing the firm fundamentals such as Return On Equity of -0.92, shares outstanding of 1.19 B, and Operating Margin of (3.42) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CStone Pharmaceuticals' price fluctuation is abnormally volatile at this time. Calculation of the real value of CStone Pharmaceuticals is based on 3 months time horizon. Increasing CStone Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CStone pink sheet is determined by what a typical buyer is willing to pay for full or partial control of CStone Pharmaceuticals. Since CStone Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CStone Pink Sheet. However, CStone Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.7 | Real 0.63 | Hype 0.7 |
The real value of CStone Pink Sheet, also known as its intrinsic value, is the underlying worth of CStone Pharmaceuticals Company, which is reflected in its stock price. It is based on CStone Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CStone Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CStone Pharmaceuticals helps investors to forecast how CStone pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CStone Pharmaceuticals more accurately as focusing exclusively on CStone Pharmaceuticals' fundamentals will not take into account other important factors: About CStone Pharmaceuticals Valuation
The pink sheet valuation mechanism determines CStone Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of CStone Pharmaceuticals. We calculate exposure to CStone Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CStone Pharmaceuticals's related companies.CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally. The company was incorporated in 2015 and is headquartered in Shanghai, China. Cstone Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 569 people.
8 Steps to conduct CStone Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CStone Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CStone Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain CStone Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CStone Pharmaceuticals' revenue streams: Identify CStone Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CStone Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish CStone Pharmaceuticals' growth potential: Evaluate CStone Pharmaceuticals' management, business model, and growth potential.
- Determine CStone Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CStone Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CStone Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as CStone Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.2 B | |
| Retained Earnings | -7.7 B |
Complementary Tools for CStone Pink Sheet analysis
When running CStone Pharmaceuticals' price analysis, check to measure CStone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CStone Pharmaceuticals is operating at the current time. Most of CStone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of CStone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CStone Pharmaceuticals' price. Additionally, you may evaluate how the addition of CStone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |